help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burguera, B.
Right arrow Articles by Caro, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burguera, B.
Right arrow Articles by Caro, J. F.

Journal of Clinical Endocrinology & Metabolism, Vol 72, 1238-1241, Copyright © 1991 by Endocrine Society

ARTICLES

The interaction of proinsulin with the insulin-like growth factor-I receptor in human liver, muscle, and adipose tissue

B Burguera, BH Frank, R DiMarchi, S Long and JF Caro
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858-4354.

Because of the sequence homology and tertiary structure similarities between proinsulin (PI) and insulin-like growth factor-I (IGF-I), it is possible that PI interacts with the IGF-I receptor with higher affinity than insulin. To test this hypothesis in man, we have partially purified IGF-I receptors from liver, muscle, and adipose tissue and studied their interaction with PI, insulin, IGF-I, and IGF-II. With some tissue to tissue variation, [125I]insulin binding was 4- to 8-fold greater than IGF-I binding. Unlabeled IGF-I at about 1 x 10(-9 M, IGF- II at about 1 x 10(-8) M, and insulin at about 1 x 10(-6) M displace 50% the binding of [125I]IGF-I to its receptor, whereas PI at 1 x 10(- 6) M displaces less than 20% of the binding of [125I]IGF-I to its receptor. We conclude that in human liver, muscle, and adipose tissue, PI does not interact with the IGF-I receptor at a higher affinity than insulin, and the affinity of IGF-I receptors is several-fold lower than that of insulin receptors. It is, therefore, unlikely that if PI were to be administered to man any of its biological effects would be by interacting with the IGF-I receptor.


This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
R. M Luque, M. D Gahete, R. J Valentine, and R. D Kineman
Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
J. Mol. Endocrinol., August 1, 2006; 37(1): 25 - 38.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. M. Luque and R. D. Kineman
Impact of Obesity on the Growth Hormone Axis: Evidence for a Direct Inhibitory Effect of Hyperinsulinemia on Pituitary Function
Endocrinology, June 1, 2006; 147(6): 2754 - 2763.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society